Coya Therapeutics

COYA51

$6.41arrow_drop_down6.75%-$0.45

COYA51

$6.41

arrow_drop_down6.75%-$0.45

Performance History

Key Stats
Open	$6.81
Prev. Close	$6.81
EPS	-0.65
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$105.59M
PE Ratio	-

	LOW	HIGH
Day Range	6.24	7.05
52 Week Range	3.94	11.45

Ratios







EPS	-0.65

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Coya Therapeutics (COYA)

Coya Therapeutics, Inc. (COYA) is a biotechnology company that focuses on the development and commercialization of innovative therapies for the treatment of various diseases. The company's stock price history shows a steady growth over the years, reflecting the market's confidence in its potential. COYA quote provided by financial websites enables investors to stay updated on the current stock price and market trends. COYA stock news offers valuable insights into the company's recent developments, such as clinical trial results, collaborations, and regulatory updates. Investors can use this information to make informed decisions about their investment in COYA.

COYA stock analysis provides a comprehensive evaluation of the company's financial performance, market position, and growth prospects. It includes an assessment of key financial ratios, such as the price-to-earnings ratio (PEG), which indicates whether the stock is overvalued or undervalued. Comparing COYA's PEG ratio with the industry average helps investors gauge its relative valuation. COYA vs industry analysis highlights the company's competitive position within the biotechnology sector, considering factors such as market share, product pipeline, and revenue growth. This information is crucial in understanding COYA's prospects for future growth and profitability.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Howard Berman Ph.D.
Headquarters: Houston
Employees: 6
Exchange: NASDAQ

Keep an eye on Coya Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Coya Therapeutics's (COYA) price per share?

The current price per share for Coya Therapeutics (COYA) is $6.42. The stock has seen a price change of -$0.46 recently, indicating a -6.75% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Coya Therapeutics (COYA)?

For Coya Therapeutics (COYA), the 52-week high is $11.46, which is 78.57% from the current price. The 52-week low is $3.94, the current price is 62.82% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Coya Therapeutics (COYA) a growth stock?

Coya Therapeutics (COYA) has shown an average price growth of -6.65% over the past three years. It has received a score of 75 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Coya Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Coya Therapeutics (COYA) stock price performance year to date (YTD)?

As of the latest data, Coya Therapeutics (COYA) has a year-to-date price change of -7.83%. Over the past month, the stock has experienced a price change of -21.96%. Over the last three months, the change has been 14.15%. Over the past six months, the figure is -26.52%.

help

Is Coya Therapeutics (COYA) a profitable company?

Coya Therapeutics (COYA) has a net income of -$7.99M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 8.34% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -116.56% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6M, although specific revenue growth data is currently not available. The gross profit is $500.68K. Operating income is noted at -$7.9M. Furthermore, the EBITDA is -$10.22M.

help

What is the market capitalization of Coya Therapeutics (COYA)?

Coya Therapeutics (COYA) has a market capitalization of $105.59M. The average daily trading volume is 6.45, indicating the stock's liquidity and investor engagement.